-
Published 9/15/2025
Frost MC, Joseph M, Bechtel JM, Hauge S, Engel CC, Kaysen D, Cerimele JM, Nolan JP, Sloan DM, Marx BP, Fortney JC. Patient perspectives on the effectiveness of written exposure therapy and medication for posttraumatic stress disorder delivered in primary care. J Trauma Stress. 2025 Sep 15. PMID: 40952792.
-
Published 7/9/2025
Kearns JC, Stanley IH, Sloan DM, Young-McCaughan S, Tyler HC, Hein JM, Straud CL, Joiner TE, Pennebaker JW, Rudd MD, Peterson AL, Marx BP. Written Exposure Therapy for Suicide Prevention (WET-SP): Design and methodology of a randomized controlled trial among military service members psychiatrically hospitalized for suicide risk. Contemp Clin Trials. 2025 Aug; 155:108001. PMID: 40645368.
-
Published 6/26/2025
Pless Kaiser A, Ream M, Spiro A, Sloan DM, Cook JM, Vogt D, Moye JA. Feasibility, acceptability, and outcomes: A pilot trial of the enhancing social function in older veterans with PTSD (ESVP) group intervention. Psychol Serv. 2025 Jun 26. PMID: 40569724.
-
Published 4/24/2025
Ismayilova J, Sloan DM, Marx BP, Chard KM, Ismayilov F, Muradova G, Sultanova A, Mammadli N, Guliyeva G, Ruzek JI. Implementation of evidence-based psychotherapies for posttraumatic stress disorder in Azerbaijan. Eur J Psychotraumatol. 2025 Dec; 16(1):2484063. PMID: 40270108.
-
Published 4/2/2025
Feder A, Brown O, Rutter SB, Cahn L, Overbey JR, Seeley SH, Yu A, Bonanno PA, Fremont RA, Delgado AA, Jha MK, Costi S, Yehuda R, Schiller D, Pietrzak RH, Charney DS, Sloan DM, Murrough JW. Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial. J Clin Psychiatry. 2025 Apr 02; 86(2). PMID: 40215385.